The differential expression of mgl mRNA by Porphyromonas gingivalis affects the production of methyl mercaptan

Oral Diseases

Volumn 21, Issue 5, 2015, Pages 626-633

  Ouhara, Kazuhisa ^a   Iwasaki, Y ^a   Kajiya, M ^a   Savitri, I ^a   Kitagawa, M ^b   Tokunaga, N ^a   Shintani, T ^b   Ogawa, I ^b   Hino, T ^a   Fujita, T ^a   Shiba, H ^a   Kurihara, H ^a,b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Porphyromonas gingivalis; Halitosis; Periodontitis; Volatile sulfur compounds

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; HERBACEOUS AGENT; MESSENGER RNA; MESSENGER RNA MGL; METHIONINE; RNA 16S; UNCLASSIFIED DRUG; METHANETHIOL; THIOL DERIVATIVE;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; GENE EXPRESSION; HALITOSIS; HUMAN; IN VITRO STUDY; MAGNOLIACEAE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION; ORIENTAL MEDICINE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; YOUNG ADULT; AGED; BACTEROIDACEAE INFECTION; BIOSYNTHESIS; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY; PERIODONTITIS; PROCEDURES;

ADULT; AGED; ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; BACTEROIDACEAE INFECTIONS; DRUGS, CHINESE HERBAL; FEMALE; HALITOSIS; HUMANS; MAGNOLIACEAE; MALE; METHIONINE; MIDDLE AGED; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFHYDRYL COMPOUNDS; YOUNG ADULT;

EID: 84930271142     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12326     Document Type: Article

References (35)

1. Aazza S, Lyoussi B, Megias C et al (2014). Anti-oxidant, anti-inflammatory and anti-proliferative activities of Moroccan commercial essential oils. Nat Prod Commun 9: 587-594.
2. Abe N, Baba A, Takii R et al (2004). Roles of Arg- and Lys-gingipains in coaggregation of Porphyromonas gingivalis: identification of its responsible molecules in translation products of rgpA, kgp, and hagA genes. Biol Chem 385: 1041-1047.
3. Amano A, Kuboniwa M, Nakagawa I, Akiyama S, Morisaki I, Hamada S (2000). Prevalence of specific genotypes of Porphyromonas gingivalis fimA and periodontal health status. J Dent Res 79: 1664-1668.
4. Amano A, Nakagawa I, Okahashi N, Hamada N (2004). Variations of Porphyromonas gingivalis fimbriae in relation to microbial pathogenesis. J Periodontal Res 39: 136-142.
5. Chu L, Ebersole JL, Kurzban GP, Holt SC (1999). Cystalysin, a 46-kDa l-cysteine desulfhydrase from Treponema denticola: biochemical and biophysical characterization. Clin Infect Dis 28: 442-450.
6. El-Shinnawi U, Soory M (2013). Associations between periodontitis and systemic inflammatory diseases: response to treatment. Recent Pat Endocr Metab Immune Drug Discov 7: 169-188.
7. Fedorowicz Z, Aljufairi H, Nasser M, Outhouse TL, Pedrazzi V (2008). Mouthrinses for the treatment of halitosis. Cochrane Database Syst Rev 8: CD006701.
8. Fujimura M, Calenic B, Yaegaki K et al (2010). Oral malodorous compound activates mitochondrial pathway inducing apoptosis in human gingival fibroblasts. Clin Oral Investig 14: 367-373.
9. Gil-Ascencio M, Castillo-Gomez CJ, Palacios-Saucedo Gdel C, Valle-de la OA (2013). Antibiotic prophylaxis in tonsillectomy and its relationship with postoperative morbidity. Acta Otorrinolaringol Esp 64: 273-278.
10. Kadowaki T, Nakayama K, Okamoto K et al (2000). Porphyromonas gingivalis proteinases as virulence determinants in progression of periodontal diseases. J Biochem 128: 153-159.
11. Kleinberg I, Westbay G (1990). Oral malodor. Crit Rev Oral Biol Med 1: 247-259.
12. Kobayashi C, Yaegaki K, Calenic B et al (2011). Hydrogen sulfide causes apoptosis in human pulp stem cells. J Endod 37: 479-484.
13. Krespi YP, Shrime MG, Kacker A (2006). The relationship between oral malodor and volatile sulfur compound-producing bacteria. Otolaryngol Head Neck Surg 135: 671-676.
14. Lee JH, Shin H, Kim YJ, Paek SH, Jin S, Ha UH (2014). Pseudomonas aeruginosa-induced IL-1beta production is inhibited by Sophora flavescens via the NF-kappaB/inflammasome pathways. J Microbiol 52: 1044-1049.
15. Liao J, Zhao L, Yoshioka M, Hinode D, Grenier D (2013). Effects of Japanese traditional herbal medicines (Kampo) on growth and virulence properties of Porphyromonas gingivalis and viability of oral epithelial cells. Pharm Biol 51: 1538-1544.
16. Liu PF, Huang IF, Shu CW, Huang CM (2013). Halitosis vaccines targeting FomA, a biofilm-bridging protein of fusobacteria nucleatum. Curr Mol Med 13: 1358-1367.
17. Morita M, Wang HL (2001). Association between oral malodor and adult periodontitis: a review. J Clin Periodontol 28: 813-819.
18. Munroe ME, Arbiser JL, Bishop GA (2007). Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J Immunol 179: 753-763.
19. Nakano Y, Yoshimura M, Koga T (2002). Correlation between oral malodor and periodontal bacteria. Microbes Infect 4: 679-683.
20. O'Brien-Simpson NM, Pathirana RD, Walker GD, Reynolds EC (2009). Porphyromonas gingivalis RgpA-Kgp proteinase-adhesin complexes penetrate gingival tissue and induce proinflammatory cytokines or apoptosis in a concentration-dependent manner. Infect Immun 77: 1246-1261.
21. Pham TA, Ueno M, Zaitsu T et al (2011). Clinical trial of oral malodor treatment in patients with periodontal diseases. J Periodontal Res 46: 722-729.
22. Ratcliff PA, Johnson PW (1999). The relationship between oral malodor, gingivitis, and periodontitis. A review. J Periodontol 70: 485-489.
23. Rylev M, Kilian M (2008). Prevalence and distribution of principal periodontal pathogens worldwide. J Clin Periodontol 35: 346-361.
24. Saito H, Kawaguchi Y (2002). Halitosis prevention campaign: a report of oral health promotion activities in Japan. Int Dent J 52(Suppl. 3): 197-200.
25. Salako NO, Philip L (2011). Comparison of the use of the Halimeter and the Oral Chroma in the assessment of the ability of common cultivable oral anaerobic bacteria to produce malodorous volatile sulfur compounds from cysteine and methionine. Med Princ Pract 20: 75-79.
26. Scully C, Rosenberg M (2003). Halitosis. Dent Update 30: 205-210.
27. Scully C, el-Maaytah M, Porter SR, Greenman J (1997). Breath odor: etiopathogenesis, assessment and management. Eur J Oral Sci 105: 287-293.
28. Shiba H, Tsuda H, Kajiya M et al (2009). Neodymium-doped yttrium-aluminium-garnet laser irradiation abolishes the increase in interleukin-6 levels caused by peptidoglycan through the p38 mitogen-activated protein kinase pathway in human pulp cells. J Endod 35: 373-376.
29. Smolik I, Robinson D, El-Gabalawy HS (2009). Periodontitis and rheumatoid arthritis: epidemiologic, clinical, and immunologic zrassociations. Compend Contin Educ Dent 30: 188-190, 192, 194 passim; quiz 198, 210.
30. Socransky SS, Haffajee AD (1994). Implications of periodontal microbiology for the treatment of periodontal infections. Compend Suppl 18: S684-S685, 688-93; quiz S714-7.
31. Sreenivasan PK, Haraszthy VI, Zambon JJ (2013). Antimicrobial efficacy of 0.05% cetylpyridinium chloride mouthrinses. Lett Appl Microbiol 56: 14-20.
32. Tonzetich J (1977). Production and origin of oral malodor: a review of mechanisms and methods of analysis. J Periodontol 48: 13-20.
33. Wang JH, Shih KS, Liou JP et al (2012). Anti-arthritic effects of magnolol in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in a rat arthritis model. PLoS ONE 7: e31368.
34. Xu X, Zhou XD, Wu CD (2010). Tea catechin EGCg suppresses the mgl gene associated with halitosis. J Dent Res 89: 1304-1308.
35. Yoshimura M, Nakano Y, Yamashita Y, Oho T, Saito T, Koga T (2000). Formation of methyl mercaptan from l-methionine by Porphyromonas gingivalis. Infect Immun 68: 6912-6916.